Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium thiosulfate for prevention of cisplatin-induced ototoxicity in SCCHN
NCT04541355Phase 2Completed
- Start
- Oct 2020
- Primary completion
- May 2023
- Countries
- 1
01
Overview
Phase 2, open-label trial of sodium thiosulfate in ototoxicity. Primary endpoint: Number of Participants Who Successfully Completed Planned Treatment at 7 weeks. Started Oct 2020; status: completed.
02
Drugs
sodium thiosulfate
03
Conditions
ototoxicity
Beyond the preview
Go deeper on NCT04541355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04541355.